<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM REMEDY
CORPORATION'S QUARTERLY REPORT ON FORM 10-Q FOR THE NINE MONTHS ENDED SEPTEMBER
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 33,286
<SECURITIES> 162,907
<RECEIVABLES> 66,849
<ALLOWANCES> 1,725
<INVENTORY> 0
<CURRENT-ASSETS> 279,061
<PP&E> 46,298
<DEPRECIATION> 27,569
<TOTAL-ASSETS> 326,915
<CURRENT-LIABILITIES> 84,135
<BONDS> 0
0
0
<COMMON> 2
<OTHER-SE> 175,193
<TOTAL-LIABILITY-AND-EQUITY> 326,915
<SALES> 118,952
<TOTAL-REVENUES> 206,037
<CGS> 7,405
<TOTAL-COSTS> 42,872
<OTHER-EXPENSES> 37,171
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 7
<INCOME-PRETAX> 33,342
<INCOME-TAX> 10,164
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 23,178
<EPS-BASIC> 0.75
<EPS-DILUTED> 0.69
</TABLE>